| Type 2 Diabetes Mellitus |
1 |
1 |
| SGLT2 Inhibitor |
0 |
0.99 |
| Coronary Artery Disease (CAD) |
0 |
0.37 |
| Cardiovascular Risk Management |
0 |
0.27 |
| Hypertension |
0 |
0.27 |
| Cardiovascular Imaging |
0 |
0.25 |
| Ejection Fraction |
0 |
0.22 |
| Heart Failure (HF) |
0 |
0.17 |
| Artery |
0 |
0.13 |
| Cardiovascular disease |
0 |
0.13 |
| Match |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Cerebrovascular Accident |
0 |
0.12 |
| Medical Life |
0 |
0.12 |
| Hemoglobin A1c |
0 |
0.09 |
| Aspirin |
0 |
0.07 |
| Beta Blockers |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Body Mass Index |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Hemoglobin |
0 |
0.07 |
| Medical Records |
0 |
0.07 |
| New York |
0 |
0.07 |
| Renin-Angiotensin System |
0 |
0.07 |
| Statins |
0 |
0.07 |
| Sulfonylureas |
0 |
0.07 |
| Lipids Management |
0 |
0.06 |
| Peripheral Artery Disease |
0 |
0.06 |